Inventor
SULLIVAN GERARD M
US40 patents
⚠️ This page may combine multiple inventors who share the name “SULLIVAN GERARD M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
20 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9315488B2Apr 19, 2016
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC13 citations92
US9029404B2May 12, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations92
US8952157B2Feb 10, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC22 citations91
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9073855B2Jul 7, 2015
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045420B2Jun 2, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9403822B2Aug 2, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC9 citations83
US8940737B2Jan 27, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC7 citations83
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US11786519B2Oct 17, 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9844547B2Dec 19, 2017
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations62
US9266877B2Feb 23, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US9227963B2Jan 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US8889675B2Nov 18, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC3 citations62
US9493431B2Nov 15, 2016
Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9156856B2Oct 13, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9877958B2Jan 30, 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations51
ABBOTT LAB
9 patentsUS8343967B2Jan 1, 2013
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBOTT LAB32 citations92
US5631401AMay 20, 1997
Inhibitors of protein farnesyltransferase and squalene synthase
ABBOTT LAB35 citations91
US7456169B2Nov 25, 2008
Heterocyclic kinase inhibitors
ABBOTT LAB9 citations83
US5783593AJul 21, 1998
Inhibitors of squalene synthetase and protein farnesyltransferase
ABBOTT LAB19 citations82
US5831115ANov 3, 1998
Inhibitors of squalene synthase and protein farnesyltransferase
ABBOTT LAB8 citations73
US7323570B2Jan 29, 2008
Farnesyltransferase inhibitors
ABBOTT LAB2 citations62
US7211595B2May 1, 2007
Farnesyltransferase inhibitors
ABBOTT LAB5 citations62
US7956185B2Jun 7, 2011
Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases
ABBOTT LAB5 citations61
US7163939B2Jan 16, 2007
Macrocyclic kinase inhibitors
ABBOTT LAB0 citations39
BRUNCKO MILAN
3 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97